Association between antipsychotics and cardiovascular adverse events

There is controversy about the association between cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients. Cardiovascular diseases are the leading cause of death worldwide and high mortality rates have been observed in patients with schizophrenia. The aim of this study is to determine whether there is an association between the risk of cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients.